应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01501 瑛泰医疗
已收盘 06-11 16:08:30
31.520
+2.020
+6.85%
最高
31.520
最低
29.500
成交量
20.22万
今开
29.700
昨收
29.500
日振幅
6.85%
总市值
66.51亿
流通市值
66.51亿
总股本
2.11亿
成交额
610.72万
换手率
0.10%
流通股本
2.11亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
瑛泰医疗(01501)存仓市值总计23.76亿港元 其中股东向中国证券登记结算香港存入7178.66万股
智通财经 · 06-04
瑛泰医疗(01501)存仓市值总计23.76亿港元 其中股东向中国证券登记结算香港存入7178.66万股
瑛泰医疗完成71,786,608股内资股转换至H股 已发行股本变动
公告速递 · 06-03
瑛泰医疗完成71,786,608股内资股转换至H股 已发行股本变动
瑛泰医疗(01501):完成H股全流通
智通财经 · 06-03
瑛泰医疗(01501):完成H股全流通
瑛泰医疗5月无新增发行或股份变动
公告速递 · 06-01
瑛泰医疗5月无新增发行或股份变动
瑛泰医疗:6月30日将派发股息0.26港元/股
南方财经网 · 05-28
瑛泰医疗:6月30日将派发股息0.26港元/股
瑛泰医疗宣派末期股息每股0.23元,拟于6月30日派付
公告速递 · 05-28
瑛泰医疗宣派末期股息每股0.23元,拟于6月30日派付
瑛泰医疗终止认购堃博医疗新股 原拟2.83亿港元交易一致撤销
公告速递 · 05-26
瑛泰医疗终止认购堃博医疗新股 原拟2.83亿港元交易一致撤销
瑛泰医疗(01501)终止认购协议
智通财经 · 05-26
瑛泰医疗(01501)终止认购协议
瑛泰医疗终止认购堃博医疗新股协议
美股速递 · 05-26
瑛泰医疗终止认购堃博医疗新股协议
瑛泰医疗(01501):联交所就实施H股全流通授出上市批准
智通财经 · 05-13
瑛泰医疗(01501):联交所就实施H股全流通授出上市批准
瑛泰医疗(01501)拟斥资约1.08亿美元收购德晋医疗23.18%股权
智通财经 · 05-12
瑛泰医疗(01501)拟斥资约1.08亿美元收购德晋医疗23.18%股权
瑛泰医疗斥资1.077亿美元,收购Valgen Holding Corporation 23.18%股权
美股速递 · 05-12
瑛泰医疗斥资1.077亿美元,收购Valgen Holding Corporation 23.18%股权
瑛泰医疗拟收购Valgen Holding Corporation 23.18%股权
美股速递 · 05-12
瑛泰医疗拟收购Valgen Holding Corporation 23.18%股权
瑛泰医疗(01501)获中国证监会发出H股全流通申请备案通知书
智通财经网 · 05-11
瑛泰医疗(01501)获中国证监会发出H股全流通申请备案通知书
瑛泰医疗2026年4月股份变动月报:股本维持稳定
公告速递 · 05-06
瑛泰医疗2026年4月股份变动月报:股本维持稳定
瑛泰医疗(01501)拟斥资3128.53万元收购璞霖医疗余下35%股权
智通财经 · 04-29
瑛泰医疗(01501)拟斥资3128.53万元收购璞霖医疗余下35%股权
瑛泰医疗签署协议 收购普霖医疗35%股权
美股速递 · 04-29
瑛泰医疗签署协议 收购普霖医疗35%股权
瑛泰医疗(01501)3,128.53万元收购剩余35%股权 璞霖医疗将成全资子公司
公告速递 · 04-29
瑛泰医疗(01501)3,128.53万元收购剩余35%股权 璞霖医疗将成全资子公司
瑛泰医疗董事会批准收购Valgen Medtech股权方案
美股速递 · 04-28
瑛泰医疗董事会批准收购Valgen Medtech股权方案
瑛泰医疗(01501)股东将股票由花旗银行转入Merrill Lynch Far East 转仓市值2.93亿港元
智通财经 · 04-28
瑛泰医疗(01501)股东将股票由花旗银行转入Merrill Lynch Far East 转仓市值2.93亿港元
暂无数据
公司概况
公司名称:
瑛泰医疗
所属市场:
SEHK
上市日期:
--
主营业务:
上海瑛泰医疗器械股份有限公司(原名:上海康德莱医疗器械股份有限公司)是一家主要从事心内介入器械研发、生产和销售的中国公司。该公司通过两个分部运营其业务。心内介入业务分部主要从事心内介入医疗器械及相关模具、标准件、面罩的销售、制造和研发。其他分部从事其他介入医疗器械的研发,例如神经介入医疗器械、心脏瓣膜植入式医疗器械。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01501","market":"HK","secType":"STK","nameCN":"瑛泰医疗","latestPrice":31.52,"timestamp":1781165310003,"preClose":29.5,"halted":0,"volume":202200,"delay":0,"changeRate":0.06847457627118643,"floatShares":211000000,"shares":211000000,"eps":1.26,"marketStatus":"已收盘","change":2.02,"latestTime":"06-11 16:08:30","open":29.7,"high":31.52,"low":29.5,"amount":6107220,"amplitude":0.068475,"askPrice":31.52,"askSize":200,"bidPrice":30.82,"bidSize":600,"shortable":3,"etf":0,"ttmEps":1.147,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781227800000},"marketStatusCode":5,"adr":0,"listingDate":1573142400000,"exchange":"SEHK","adjPreClose":29.5,"dividendRate":0.008424,"openAndCloseTimeList":[[1781141400000,1781150400000],[1781154000000,1781164800000]],"volumeRatio":1.186341,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603987","market":"SH","secType":"STK","nameCN":"康德莱","latestPrice":7.19,"timestamp":1781161200000,"preClose":7.25,"halted":0,"volume":3746000,"delay":0,"premium":"+279.35"}},"requestUrl":"/m/hq/s/01501/tweets","defaultTab":"tweets","newsList":[{"id":"2640359138","title":"瑛泰医疗(01501)存仓市值总计23.76亿港元 其中股东向中国证券登记结算香港存入7178.66万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640359138","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640359138?lang=zh_cn&edition=full","pubTime":"2026-06-04 08:18","pubTimestamp":1780532324,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,6月3日,瑛泰医疗(01501)出现仓位异动,存仓市值总计23.76亿港元,占比33.99%。该公司股东将股票存入中国证券登记结算香港7178.66万股,持股比例增加21.11%。瑛泰医疗公告,7178.66万股内资股转换为H股已于2026年6月3日完成,而7178.66万股经转换H股将于2026年6月4日上午九时正开始于联交所上市。参与股东须在完成适用的境内安排程序后,方可进行经转换H股交易。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449916.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01501","161027","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185129764","title":"瑛泰医疗完成71,786,608股内资股转换至H股 已发行股本变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1185129764","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185129764?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:58","pubTimestamp":1780477107,"startTime":"0","endTime":"0","summary":"瑛泰医疗(01501)于2026年6月3日发布公告,宣布将12名参与股东所持有的71,786,608股内资股转换为H股。该部分转股占转换前公司已发行股本的33.99%。\n公司在本次转换并上市后已发行股本总数维持211,200,000股H股,此前境内上市的内资股则由71,786,608股降至0股。公司表示有关注册转换与上市所需的法律规定及香港联交所相关上市规则,并确认所有程序均已获得董事会正式授权并遵守适用的法律及监管规定。\n本次公告由公司董事长兼执行董事梁栋科签署。公司称,此次转股完成后,其已发行股份的整体架构调整已顺利实施。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"瑛泰医疗完成71,786,608股内资股转换至H股 已发行股本变动","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640972220","title":"瑛泰医疗(01501):完成H股全流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2640972220","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640972220?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:31","pubTimestamp":1780475480,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑛泰医疗(01501)发布公告,7178.66万股内资股转换为H股已于2026年6月3日完成,而7178.66万股经转换H股将于2026年6月4日上午九时正开始于联交所上市。参与股东须在完成适用的境内安排程序后,方可进行经转换H股交易。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449586.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"瑛泰医疗(01501):完成H股全流通","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179736144","title":"瑛泰医疗5月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1179736144","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179736144?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:56","pubTimestamp":1780304185,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司(01501)于2026年6月1日发布2026年5月股份变动月报表,披露了公司截至2026年5月31日的股本及股份变动情况。\n公告显示,报告期内公司已发行股本结构保持不变,未发生新增发行、股份购回、注销或库藏股变动。截至2026年5月末,公司已发行股本总额为人民币211,200,000元,其中国际上市的H股139,413,392股(面值人民币1元),内资股71,786,608股(面值人民币1元)。\n公司同时确认,当前已满足香港联交所主板上市规则对于公众持股量的具体要求。本次公告由公司主席兼执行董事梁栋科签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638698506","title":"瑛泰医疗:6月30日将派发股息0.26港元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638698506","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638698506?lang=zh_cn&edition=full","pubTime":"2026-05-28 19:44","pubTimestamp":1779968640,"startTime":"0","endTime":"0","summary":"南财智讯5月28日电,瑛泰医疗(01501.HK)公告,公司于2026年5月28日举行的股东周年大会上,批准截至2025年12月31日止年度的末期股息为每股人民币0.23元(相当于每股0.26港元)。为确定有权收取股息的股东名单,公司将于2026年6月5日至6月10日暂停办理股份过户登记手续。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605283752947984.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","01501","BK1222","VIG","EWH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136635404","title":"瑛泰医疗宣派末期股息每股0.23元,拟于6月30日派付","url":"https://stock-news.laohu8.com/highlight/detail?id=1136635404","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136635404?lang=zh_cn&edition=full","pubTime":"2026-05-28 19:41","pubTimestamp":1779968487,"startTime":"0","endTime":"0","summary":"瑛泰医疗公告,公司于2026年5月28日举行的股东周年大会上,正式通过截至2025年12月31日止年度的利润分配方案,批准派发末期股息每股人民币0.23元(含税),折合每股0.26港元。此次股息以人民币计值及宣派。拟派末期股息预计于2026年6月30日或前后向名列当日股东名册的股东派付。港元兑换汇率采用董事会通过宣派股息之日前五个工作日中国人民银行公布的港元兑人民币汇率平均值,即1.135港元兑1.00元人民币,据此每股H股末期股息为0.26港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"瑛泰医疗宣派末期股息每股0.23元,拟于6月30日派付","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136786546","title":"瑛泰医疗终止认购堃博医疗新股 原拟2.83亿港元交易一致撤销","url":"https://stock-news.laohu8.com/highlight/detail?id=1136786546","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136786546?lang=zh_cn&edition=full","pubTime":"2026-05-26 18:52","pubTimestamp":1779792722,"startTime":"0","endTime":"0","summary":"瑛泰医疗与堃博医疗控股有限公司于2026年5月26日签署终止协议,双方一致解除2025年10月10日订立的认购协议,并取消原计划进行的全部交易安排。根据2025年认购协议,瑛泰医疗曾计划以每股3.11港元认购堃博医疗91,093,613股新股份,总对价约2.83亿港元。公告指出,截至终止协议签署日期,瑛泰医疗尚未就该认购向堃博医疗支付任何款项。瑛泰医疗董事会表示,终止该认购不会对集团的财务状况及营运构成重大不利影响,且符合公司及股东整体利益。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638333516","title":"瑛泰医疗(01501)终止认购协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2638333516","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638333516?lang=zh_cn&edition=full","pubTime":"2026-05-26 18:49","pubTimestamp":1779792550,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑛泰医疗(01501)发布公告,内容有关根据本公司与堃博医疗控股有限公司(堃博医疗,股份代号:2216)所订立日期为2025年10月10日的认购协议认购9109.36万股堃博医疗新股份,认购价为每股认购股份3.11港元,总代价为2.83亿港元。于2026年5月26日,本公司与堃博医疗订立终止协议,据此,双方一致同意终止认购协议及其项下拟进行的交易。根据终止协议,认购协议项下的所有义务及责任悉数且不可撤销地解除(各项认购协议项下的保密责任除外),双方就此概无任何相互申索的权利(各项认购协议项下的保密责任除外)。于本公告日期,本公司尚未根据认购协议向堃博医疗支付任何代价。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446127.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01501","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143071115","title":"瑛泰医疗终止认购堃博医疗新股协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1143071115","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143071115?lang=zh_cn&edition=full","pubTime":"2026-05-26 18:47","pubTimestamp":1779792466,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司宣布,已终止此前与堃博医疗就认购其新发行股份达成的协议。该决定意味着,相关股份认购计划将不再推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1222","01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635278289","title":"瑛泰医疗(01501):联交所就实施H股全流通授出上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2635278289","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635278289?lang=zh_cn&edition=full","pubTime":"2026-05-13 20:23","pubTimestamp":1778674980,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑛泰医疗(01501)发布公告,本公司已向联交所上市委员会申请批准根据转换12名股东持有的7178.66万股内资股(转换)而拟转换的7178.66万股H股(经转换H股)上市及买卖经转换H股(上市批准)。本公司欣然宣布,联交所已于2026年5月13日授出上市批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441391.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","BK1222","01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634248670","title":"瑛泰医疗(01501)拟斥资约1.08亿美元收购德晋医疗23.18%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2634248670","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634248670?lang=zh_cn&edition=full","pubTime":"2026-05-12 22:41","pubTimestamp":1778596903,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑛泰医疗 公布,于2026年5月11日及2026年5月12日,公司就以总对价约1.08亿美元收购Valgen Holding Corporation23.18%股权,分别与卖方订立股份转让协议。据悉,目标公司持有德晋医疗100%股权。德晋医疗主要从事房室瓣疾病方面介入治疗技术及产品的研发、生产及销售。德晋医疗为目标集团在中国的主要经营实体。其中,DragonFly经导管二尖瓣夹系统为国家药监局批准的首款国产经导管二尖瓣产品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440925.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159891","BK1222","01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198395251","title":"瑛泰医疗斥资1.077亿美元,收购Valgen Holding Corporation 23.18%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1198395251","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198395251?lang=zh_cn&edition=full","pubTime":"2026-05-12 22:39","pubTimestamp":1778596752,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司达成一项交易,以107,758,127美元的价格,收购Valgen Holding Corporation 23.18%的股权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152812105","title":"瑛泰医疗拟收购Valgen Holding Corporation 23.18%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1152812105","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152812105?lang=zh_cn&edition=full","pubTime":"2026-05-12 22:39","pubTimestamp":1778596750,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司宣布,将收购Valgen Holding Corporation的23.18%股权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634288870","title":"瑛泰医疗(01501)获中国证监会发出H股全流通申请备案通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2634288870","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634288870?lang=zh_cn&edition=full","pubTime":"2026-05-11 18:47","pubTimestamp":1778496427,"startTime":"0","endTime":"0","summary":"瑛泰医疗(01501)公布,公司已就将公司12名股东持有的合共71,786,608股内资股转换为H股,代表该等12名股东向中国证监会提出申请。董事会宣布,于2026年5月9日,公司已收到日期为2026年4月27日且由中国证监会就H股全流通发出的上海瑛泰医疗器械股份有限公司境内未上市股份全流通备案通知书。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_31.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_31.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440296.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1222","01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162539638","title":"瑛泰医疗2026年4月股份变动月报:股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1162539638","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162539638?lang=zh_cn&edition=full","pubTime":"2026-05-06 16:48","pubTimestamp":1778057319,"startTime":"0","endTime":"0","summary":"2026年5月6日,上海瑛泰医疗器械股份有限公司发布截至2026年4月30日的股份变动月报表。公告显示,公司本月未发生新增股份发行、回购、注销或库藏股等变动。截至2026年4月末,公司确认满足香港联交所关于公众持股量的规定,整体股本保持稳定。公司表示已遵守香港联交所《上市规则》及相关法律法规的要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8d4c202617d87be1d9fe31f833a300a8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631551023","title":"瑛泰医疗(01501)拟斥资3128.53万元收购璞霖医疗余下35%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2631551023","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631551023?lang=zh_cn&edition=full","pubTime":"2026-04-29 21:57","pubTimestamp":1777471047,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑛泰医疗(01501)发布公告,于2026年4月29日,该公司拟李晓玲女士、陈晓女士及李少伟女士收购璞霖医疗35%股权,合计对价(含税)为3128.53万元。于股权收购完成后,璞霖医疗将成为公司的全资附属公司。璞霖医疗系公司重要的附属公司,主要负责集团在国内的医疗器械市场推广和销售。董事会认为,股权收购符合公司的战略发展目标,收购有助于促进集团整体经营管控和业务协同发展效率。完成股权收购后,公司将充分发挥璞霖医疗在医疗器械销售领域的专业化、标准化的优势,协同整合璞霖医疗在管项目,持续提高运营效能,以提升公司整体的可持续发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436643.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","01501","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159894180","title":"瑛泰医疗签署协议 收购普霖医疗35%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1159894180","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159894180?lang=zh_cn&edition=full","pubTime":"2026-04-29 21:55","pubTimestamp":1777470932,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司宣布,已正式签署股权收购协议,将收购普霖医疗35%的股权。此次交易标志着公司在医疗器械领域的战略布局进一步深化。\n通过本次股权收购,瑛泰医疗有望与普霖医疗形成业务协同效应,整合双方在研发、生产和市场渠道方面的资源优势。这一举措将强化公司在医疗器械行业的市场地位,为未来业务拓展奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1222","01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102524325","title":"瑛泰医疗(01501)3,128.53万元收购剩余35%股权 璞霖医疗将成全资子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1102524325","media":"公告速递","labels":["shareholding","merge","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102524325?lang=zh_cn&edition=full","pubTime":"2026-04-29 21:51","pubTimestamp":1777470694,"startTime":"0","endTime":"0","summary":"4月29日,瑛泰医疗公告称,公司已与三名自然人股东签订股权收购协议,将以总价3,128.53万元收购上海璞霖医疗器械有限公司剩余35%股权。交易完成后,璞霖医疗持股结构将由“瑛泰医疗65%、其他股东35%”转变为“瑛泰医疗100%”,璞霖医疗晋升为其全资子公司。公告提醒,股权收购须待协议所列全部先决条件达成后方能生效,投资者买卖公司证券时应保持审慎。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160163974","title":"瑛泰医疗董事会批准收购Valgen Medtech股权方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1160163974","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160163974?lang=zh_cn&edition=full","pubTime":"2026-04-28 20:29","pubTimestamp":1777379363,"startTime":"0","endTime":"0","summary":"瑛泰医疗(股票代码:01501)近日宣布,公司董事会已正式审议通过收购Valgen Medtech股权的议案。此次战略性投资将有助于公司拓展医疗器械领域的产业布局,进一步提升在高端医疗设备市场的竞争力。董事会认为,本次收购符合公司长期发展战略,有望为股东创造可持续的价值回报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630412773","title":"瑛泰医疗(01501)股东将股票由花旗银行转入Merrill Lynch Far East 转仓市值2.93亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630412773","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630412773?lang=zh_cn&edition=full","pubTime":"2026-04-28 08:22","pubTimestamp":1777335739,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,4月27日,瑛泰医疗(01501)股东将股票由花旗银行转入Merrill Lynch Far East,转仓市值2.93亿港元,占比5.43%。此前瑛泰医疗发布截至2025年12月31日止年度业绩,收入10.65亿元,同比增长25.06%;毛利6.37亿元,同比增长18.44%;净利2.33亿元,同比增长22.43%;每股盈利1.26元。拟派股息每股0.23元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434988.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0170899867.USD","BK4534","LU0052756011.USD","LU0477156953.USD","BK4559","LU2462157665.USD","LU1201861249.SGD","LU2456880835.USD","BK1222","LU2417539215.USD","LU1162221912.USD","LU1668664300.SGD","LU0130102774.USD","LU1244550577.SGD","LU1506573853.SGD","LU0098860793.USD","LU1244550494.USD","LU0980610538.SGD","LU0130517989.USD","BK4566","LU2125154935.USD","BK4588","01501","LU0314106906.USD","LU1791807156.HKD","LU0072461881.USD","LU1267930227.SGD","LU2360032135.SGD","BK4504","LU0162691827.USD","LU2125154778.USD","BK4207","LU1244550221.USD","BK4585","LU0106831901.USD","LU0128525689.USD","LU0648001328.SGD","LU1366192091.USD","IE00BSNM7G36.USD","LU2236285917.USD","LU0320765646.SGD","LU0310800965.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kdlchina.com","stockEarnings":[{"period":"1week","weight":-0.0884},{"period":"1month","weight":-0.2461},{"period":"3month","weight":-0.0365},{"period":"6month","weight":-0.0408},{"period":"1year","weight":0.2653},{"period":"ytd","weight":-0.0082}],"compareEarnings":[{"period":"1week","weight":-0.0478},{"period":"1month","weight":-0.0757},{"period":"3month","weight":-0.0509},{"period":"6month","weight":-0.0604},{"period":"1year","weight":0.0101},{"period":"ytd","weight":-0.0477}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海瑛泰医疗器械股份有限公司(原名:上海康德莱医疗器械股份有限公司)是一家主要从事心内介入器械研发、生产和销售的中国公司。该公司通过两个分部运营其业务。心内介入业务分部主要从事心内介入医疗器械及相关模具、标准件、面罩的销售、制造和研发。其他分部从事其他介入医疗器械的研发,例如神经介入医疗器械、心脏瓣膜植入式医疗器械。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.045707},{"month":2,"riseRate":0.285714,"avgChangeRate":0.009958},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.013734},{"month":4,"riseRate":0.714286,"avgChangeRate":0.03758},{"month":5,"riseRate":0.285714,"avgChangeRate":0.072512},{"month":6,"riseRate":0.428571,"avgChangeRate":0.051057},{"month":7,"riseRate":0.666667,"avgChangeRate":0.01185},{"month":8,"riseRate":0.666667,"avgChangeRate":0.02216},{"month":9,"riseRate":0.5,"avgChangeRate":-0.072581},{"month":10,"riseRate":0.5,"avgChangeRate":0.064903},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.077012},{"month":12,"riseRate":0.714286,"avgChangeRate":0.030589}],"exchange":"SEHK","name":"瑛泰医疗","nameEN":"INT MEDICAL"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑛泰医疗(01501)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑛泰医疗(01501)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑛泰医疗,01501,瑛泰医疗股票,瑛泰医疗股票老虎,瑛泰医疗股票老虎国际,瑛泰医疗行情,瑛泰医疗股票行情,瑛泰医疗股价,瑛泰医疗股市,瑛泰医疗股票价格,瑛泰医疗股票交易,瑛泰医疗股票购买,瑛泰医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑛泰医疗(01501)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑛泰医疗(01501)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}